PFAS restrictions and medicines: what is the EU proposing, and how it might affect lung cancer treatment
The EU is consulting on new restrictions on PFAS chemicals, also known as “forever chemicals.” Lung Cancer Europe explains what the proposed regulation involves, why it matters for medicine supply, and how we are engaging with the process.
Blood test predicts lung cancer five years early: what the new Cell research means
Scientists at the Francis Crick Institute and UCL have identified 14 proteins in blood that can predict lung cancer more than five years before diagnosis. The research, published in Cell on 4 June 2026, also points toward a prevention strategy. Here is what it found and why it matters for people affected by lung cancer across Europe.
